A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Study Director
Takeda
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucla Health-Santa Monica Cancer Care (cancer Care - Santa Monica)
Santa Monica, California, United States
Joel Randolph HechtRecruiting - Yale School of Medicine - Smilow Cancer Hospital - Center for Thoracic Cancers
New Haven, Connecticut, United States
So Yeon KimRecruiting - Florida Cancer Specialists - Lake Nona
Orlando, Florida, United States
Cesar PerezRecruiting - Johns Hopkins
Baltimore, Maryland, United States
Vincent LamNot, yet, recruiting - Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States
Wasif SaifRecruiting - Start Midwest
Grand Rapids, Michigan, United States
Manish SharmaRecruiting - Washington University
St Louis, Missouri, United States
Douglas AdkinsRecruiting - Recruiting
- Providence Cancer Institute, Franz Clinic
Portland, Oregon, United States
Rachel SanbornRecruiting - Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
Anthony OlszanskiRecruiting - Scri Oncology
Nashville, Tennessee, United States
Meredith PelsterRecruiting - Md Anderson Cancer Center
Houston, Texas, United States
Stephane ChampiatNot, yet, recruiting - Next Dallas
Irving, Texas, United States
Michael SongRecruiting - Start San Antonio
San Antonio, Texas, United States
Drew RascoRecruiting - Next Virginia
Fairfax, Virginia, United States
Alexander SpiraRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Nov 2025
- Primary completion
- 26 Dec 2028
- Completion
- 21 Dec 2029
- Last update posted
- 15 Jun 2026
- Registered enrollment
- 223
- Registry id
- NCT07205718
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.